Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Novo Nordisk, Hims & Hers Health Shares React to Lawsuit
03:44pm, Monday, 09'th Feb 2026
Pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) revealed today it is pursing legal action against Hims & Hers Health Inc (NYSE:HIMS) for alleged patent infringement, after the telehealth giant in
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
03:05pm, Monday, 09'th Feb 2026
LOS ANGELES--(BUSINESS WIRE)---- $HIMS--HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm.
The Danish drugmaker's patent lawsuit is the company's latest effort to shore up its place in the booming weight-loss drug market.
FDA Uncertainty Pushes Analyst To Lower Hims & Hers Forecast
01:44pm, Monday, 09'th Feb 2026
• Hims & Hers Health stock is at significant support. What's pressuring HIMS?
Hims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War
01:03pm, Monday, 09'th Feb 2026
Shares of Hims & Hers crashed to new 52-week lows on Monday, under the weight of much uncertainty.
Hims & Hers Stock Plunges While Novo Nordisk Gains as Weight-Loss Drug Wars Take New Turn
12:21pm, Monday, 09'th Feb 2026
Hims & Hers Health shares are tumbling after a major blow to its weight-loss lineup.
Hims & Hers Health Faces Legal and Regulatory Challenges, Stock Plummets
12:14pm, Monday, 09'th Feb 2026
Hims and Hers Health (HIMS) is experiencing a significant drop in stock value due to aggressive legal action and regulatory challenges. The telehealth provider is
Hims & Hers is scrapping its plan for a knockoff Wegovy weight-loss pill. Here's why
12:01pm, Monday, 09'th Feb 2026
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug and one day after the Food and Drug
HIMs 22% Collapse Looks Like A ‘Buy The Dip' Moment
11:59am, Monday, 09'th Feb 2026
Shares of Hims & Hers Health (NYSE:HIMS) plunged 22% at market open on Monday, February 9.
Why Hims & Hers Stock Just Got Destroyed
11:42am, Monday, 09'th Feb 2026
Hims & Hers Health announced it will sell Ozempic lookalike pills for $49 a month last week. The FDA objected Friday, and Novo Nordisk sued for patent infringement this morning.
Nasdaq powers ahead, Dow Jones notches new closing record
11:10am, Monday, 09'th Feb 2026
4:10pm: Fresh highs Another strong day on Wall Street saw the Dow Jones notch a new closing record of 50,136, up 20 points. The Nasdaq added 0.9% at 23,238...
HIMS Slides 25% After NVO Sues Company Over Generic GLP-1 Pills
11:00am, Monday, 09'th Feb 2026
Legal issues hits Hims & Hers (HIMS). Novo Nordisk (NVO) filed a lawsuit against the company over allegedly selling unapproved Wegovy and Ozempic weight loss drugs.
Hims & Hers Falls Apart, Again
10:39am, Monday, 09'th Feb 2026
Hims & Hers Health (NASDAQ: HIMS) has had among the worst runs of any public company over the last year.
HIMS Stock Tumbles as FDA Scrutiny Boosts Novo Nordisk Shares
10:24am, Monday, 09'th Feb 2026
Hims and Hers (HIMS)stock dipped 15% on early Monday trading after halting sales of a $49 compounded semaglutide pill after regulators raised concerns.On the othe
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pills, injections
10:04am, Monday, 09'th Feb 2026
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker's new Wegovy obesity pill and injections in the U.S. CNBC'
